Key Events This Week
16 Nov: Week opens at Rs.1,394.00 with marginal gain
18 Nov: Intraday high of Rs.1,425.00 with 3.17% surge
18 Nov: Surge in call option activity near Rs.1,430 strike
18 Nov: Sharp 31.74% jump in derivatives open interest
20 Nov: Week closes at Rs.1,414.95, up 1.58%
P/E at 36.8 vs Industry's 39.5: What the Data Shows for Cipla Ltd.
Valuation Picture: A Slight Discount to Industry P/E
The current P/E of 36.84 for Cipla Ltd. represents a modest discount of approximately 6.8% relative to the sector average of 39.53. This suggests that the market is pricing the stock with a slightly more cautious outlook compared to its peers. Given the pharmaceutical sector’s typical premium valuations driven by innovation and patent portfolios, Cipla’s valuation indicates tempered expectations, possibly reflecting recent performance challenges or sector headwinds. Cipla Ltd.’s large-cap status with a market capitalisation of...
Read MoreP/E at 36.94 vs Industry's 39.30: What the Data Shows for Cipla Ltd.
Valuation Picture: Discount to Industry P/E
Cipla Ltd. currently trades at a P/E of 36.94, which is approximately 6.1% below the Pharmaceuticals & Biotechnology industry average of 39.30. This discount suggests that the market is pricing in either a relatively subdued growth outlook or concerns over near-term earnings momentum compared to its sector peers. Given the sector’s average valuation, Cipla’s lower P/E could be interpreted as a valuation cushion, but it also raises questions about the sustainability of its earnings trajectory. Cipla Ltd.’s market capitalisation stands a...
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Nov-2026 | Source : BSENewspaper advertisement for Notice of Postal Ballot and e-voting information.
Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge Long Island New York USA
17-Nov-2026 | Source : BSEPlease find enclosed intimation
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
16-Nov-2026 | Source : BSEPostal Ballot Notice dated 27th October 2026.
Corporate Actions 
No Upcoming Board Meetings
Cipla Ltd. has declared 650% dividend, ex-date: 05 Jun 26
No Splits history available
Cipla Ltd. has announced 3:2 bonus issue, ex-date: 24 Apr 06
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 46 Schemes (20.78%)
Held by 817 FIIs (20.25%)
Yusuf Khwaja Hamied (18.69%)
Lici Ulip-growth Fund (9.75%)
13.41%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 4.00% vs 8.84% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 11.21% vs 42.26% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 5.83% vs 5.67% in Sep 2024
Growth in half year ended Sep 2025 is 6.80% vs 16.63% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.86% vs 6.16% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -17.93% vs 27.28% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 2.23% vs 6.88% in Mar 2025
YoY Growth in year ended Mar 2026 is -26.43% vs 27.93% in Mar 2025